MAPT and Alzheimer disease: Several tau-PET studies have shown that amyloid-positive individual’s exhibit elevated tau accumulation in the amygdala, even in the absence of cognitive decline, suggesting that pathological changes in the amygdala in AD may begin prior to the onset of cognitive symptoms [3, 6, 7].